Overview

A Safety Trial of DAS181 (Fludase®) in Adult Subjects With Well-Controlled Asthma or Bronchiectasis

Status:
Completed
Trial end date:
2011-08-22
Target enrollment:
Participant gender:
Summary
The primary objective is to evaluate whether DAS181 is safe in subjects with well-controlled asthma or bronchiectasis.
Phase:
Phase 1
Details
Lead Sponsor:
Ansun Biopharma, Inc.
Collaborator:
National Institutes of Health (NIH)